UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2015-11, Vol.373 (19), p.1803-1813

2015

Volltextzugriff (PDF)

A Fatal Case of Life-Threatening Interstitial Pneumonitis Induced by Everolimus for Metastatic Renal Cell Carcinoma: A Comment about the Increased Risk of Interstitial Lung Disease in Japanese

Case reports in urology, 2019, Vol.2019 (2019), p.1-4

2019

Volltextzugriff (PDF)

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma

European urology, 2017-12, Vol.72 (6), p.962-971

2017

Volltextzugriff (PDF)

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4068-4075

2009

Volltextzugriff (PDF)

mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer

PloS one, 2012-11, Vol.7 (11), p.e49144-e49144

2012

Volltextzugriff (PDF)

Effect of Sagittal Dentoskeletal Discrepancies on the Vermilion Height and Lip Area

Turkish Journal of Orthodontics, 2019-06, Vol.32 (2), p.79-86

2019

Volltextzugriff (PDF)

Epidemiology and Burden of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections in Bone Marrow Transplant and Hematology-Oncology Units

American journal of infection control, 2017-06, Vol.45 (6), p.S38-S38

2017

Volltextzugriff (PDF)

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

The New England journal of medicine, 2021-09, Vol.385 (12), p.1091-1103

2021

Volltextzugriff (PDF)

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

Annals of internal medicine, 1993-11, Vol.119 (9), p.874

1993

Volltextzugriff (PDF)

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

The lancet oncology, 2020-12, Vol.21 (12), p.1574-1588

2020

Volltextzugriff (PDF)

Hyper IgE Syndrome and Renal Cell Carcinoma

Case reports in urology, 2017-01, Vol.2017 (2017), p.1-3

2017

Volltextzugriff (PDF)

Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse Events Using FDG-PET/CT

Clinical nuclear medicine, 2019-04, Vol.44 (4), p.e272-e279

2019

Volltextzugriff (PDF)

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

The lancet oncology, 2022-02, Vol.23 (2), p.248-258

2022

Volltextzugriff (PDF)

Femoral Metastasis from Penile Carcinoma: Report of 2 Cases

Case reports in urology, 2015, Vol.2015 (2015), p.1-3

2015

Volltextzugriff (PDF)

Metastatic Tumor of the Spermatic Cord in Adults: A Case Report and Review

Case reports in urology, 2015-01, Vol.2015 (2015), p.1-7

2015

Volltextzugriff (PDF)

Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy

Journal of cutaneous pathology, 2016-04, Vol.43 (4), p.339-346

2016

Volltextzugriff (PDF)

Exploring Factors Influencing Analytical Decision-Making Impacting Analytical Transformation in Global Organizations

Organization development journal, 2024-10, Vol.42 (3), p.57-73

2024

Volltextzugriff (PDF)

Factors influencing dynamic capabilities of entrepreneurial-led organisations to achieve analytical transformation

International journal of business environment, 2023, Vol.1 (1)

2023

Volltextzugriff (PDF)

Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma

Journal of the American Academy of Dermatology, 2021-12, Vol.85 (6), p.1610-1611

2021

Volltextzugriff (PDF)

A pilot study to determine out‐of‐pocket expenditures by families of children being treated for cancer at public hospitals in New Delhi, India

Psycho-oncology (Chichester, England), 2019-06, Vol.28 (6), p.1349-1353

2019

Volltextzugriff (PDF)

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

Journal of clinical oncology, 2024-04, Vol.42 (11), p.1222-1228

2024

Volltextzugriff (PDF)

EXAMINING HUMAN RESOURCE FACTORS INFLUENCING ANALYTICAL DECISION MAKING AND ORGANIZATIONAL EFFECTIVENESS IN TECHNOLOGY DRIVEN COMPANIES

International Journal of Professional Business Review, 2024-02, Vol.9 (2), p.e04296

2024

Volltextzugriff (PDF)

Consolidative radiotherapy in metastatic urothelial cancer (MUC)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.406-406

2016

Volltextzugriff (PDF)

Real world chart review of adverse event management in patients taking tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC) by line of therapy (LoT)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.521-521

2016

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(155)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

A Fatal Case of Life-Threatening Interstitial Pneumonitis Induced by Everolimus for Metastatic Renal Cell Carcinoma: A Comment about the Increased Risk of Interstitial Lung Disease in Japanese

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer

Effect of Sagittal Dentoskeletal Discrepancies on the Vermilion Height and Lip Area

Epidemiology and Burden of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections in Bone Marrow Transplant and Hematology-Oncology Units

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Hyper IgE Syndrome and Renal Cell Carcinoma

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse Events Using FDG-PET/CT

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

Femoral Metastasis from Penile Carcinoma: Report of 2 Cases

Metastatic Tumor of the Spermatic Cord in Adults: A Case Report and Review

Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy

Exploring Factors Influencing Analytical Decision-Making Impacting Analytical Transformation in Global Organizations

Factors influencing dynamic capabilities of entrepreneurial-led organisations to achieve analytical transformation

Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma

A pilot study to determine out‐of‐pocket expenditures by families of children being treated for cancer at public hospitals in New Delhi, India

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

EXAMINING HUMAN RESOURCE FACTORS INFLUENCING ANALYTICAL DECISION MAKING AND ORGANIZATIONAL EFFECTIVENESS IN TECHNOLOGY DRIVEN COMPANIES

Consolidative radiotherapy in metastatic urothelial cancer (MUC)

Real world chart review of adverse event management in patients taking tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC) by line of therapy (LoT)

Suchergebnisse filtern